Chitkara, A.; Sreenivasan, S.; Yin, Y.; Rai, M.; Sadashiv, S.
Venous Thromboembolism Risk in Hematological Malignancies Post-Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: A Meta-Analysis of Phase 2 and Phase 3 Clinical Trials. Curr. Oncol. 2024, 31, 4338-4345.
https://doi.org/10.3390/curroncol31080323
AMA Style
Chitkara A, Sreenivasan S, Yin Y, Rai M, Sadashiv S.
Venous Thromboembolism Risk in Hematological Malignancies Post-Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: A Meta-Analysis of Phase 2 and Phase 3 Clinical Trials. Current Oncology. 2024; 31(8):4338-4345.
https://doi.org/10.3390/curroncol31080323
Chicago/Turabian Style
Chitkara, Akshit, Sushanth Sreenivasan, Yue Yin, Maitreyee Rai, and Santhosh Sadashiv.
2024. "Venous Thromboembolism Risk in Hematological Malignancies Post-Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: A Meta-Analysis of Phase 2 and Phase 3 Clinical Trials" Current Oncology 31, no. 8: 4338-4345.
https://doi.org/10.3390/curroncol31080323
APA Style
Chitkara, A., Sreenivasan, S., Yin, Y., Rai, M., & Sadashiv, S.
(2024). Venous Thromboembolism Risk in Hematological Malignancies Post-Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: A Meta-Analysis of Phase 2 and Phase 3 Clinical Trials. Current Oncology, 31(8), 4338-4345.
https://doi.org/10.3390/curroncol31080323